1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Demographics of patients with AIS undergoing interventional therapies
<75 Years of Age ≥75 Years of Age Patients 70 (65%) 37 (35%) Mean age 60 ± 13 80 ± 4 Sex Male 40 (57%) 14 (38%) Female 30 (43%) 23 (62%) LDL 83 ± 37a 65 ± 29a INR value 1.1 ± .25 1.2 ± .37 Warfarin use 9 (12%) 10 (24%) Statin use 19 (44%) 18 (56%) Diabetes 15 (19%) 13 (32%) Hypertension 51 (65%)a 34 (82%)a Heart disease 29 (37%) 20 (49%) Atrial fibrillation 23 (30%)a 21 (51%)a Admission NIHSS score Median 17.5 18 IQR 12.75–21 16–22.5 Prestroke mBI Median 20a 19a IQR 20–20 19–20
↵a P < .05, χ2 test.